Research progress in the application of immunotherapy combined with precision medicine in managing liver cancer / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
;
(12): 712-716, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-957030
ABSTRACT
Liver cancer has a high degree of malignancy and its prognosis is poor. The biological behavior of liver cancer with its high degree of malignancy and high tumor heterogeneity impact on its therapeutic effect. The rapid development of precision therapy in the field of cancer provides a platform for application of the precision therapy mode in liver cancer treatment. This article reviews the combined impact by using immune checkpoint inhibitors therapy under precision medicine with targeted therapy, radiotherapy, chemotherapy, oncolytic viruses, tumor vaccines, fecal bacteria transplantation and other therapies.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Hepatobiliary Surgery
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS